Zobrazeno 1 - 10
of 30
pro vyhledávání: ''
Autor:
Yoshikazu Takahashi, Hidekazu Shirota, Takashi Yoshioka, Takuhiro Yamaguchi, Kota Ouchi, Michio Kuroki, Shin Takahashi, Masahiro Takahashi, Masaki Tanaka, Masanobu Takahashi, Chikashi Ishioka, Yasuhiro Sakamoto, Hideki Shimodaira, Hiroo Imai, Satoshi Kato, Keigo Komine, Kazunori Otsuka, Hiroyuki Shibata, Hisatsugu Ohori, Hiroaki Yamaguchi, Yasushi Tsuji
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose The current study aimed to determine the efficacy of trifluridine/tipiracil for elderly patients with advanced colorectal cancer. Methods This single-arm, open-label, multicenter, phase II study included elderly patients aged 65 years or more
Autor:
M.T. Huizing, Stephen Chan, Stefania Russo, Gail S. Wright, Joyce Steinberg, Andrew M Wardley, Ron Bose, Robyn R. Young, A. Jo Chien, Iulia Cristina Tudor, Andrea Rocca, Lowell L. Hart, Javier Cortes, Kathy D. Miller, Hope S. Rugo, Marie-Pascale Graas, Louise Provencher, Patrick Neven, Jennifer Sugg, Ian E. Krop, David Cameron, Vandana G. Abramson
Publikováno v:
Wardley, A, Cortes, J, Provencher, L, Miller, K, Chien, A J, Rugo, H S, Steinberg, J, Sugg, J, Tudor, I C, Huizing, M, Young, R, Abramson, V, Bose, R, Hart, L, Chan, S, Cameron, D, Wright, G S, Graas, M, Neven, P, Rocca, A, Russo, S & Krop, I E 2021, ' The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer ', Breast cancer research and treatment . https://doi.org/10.1007/s10549-021-06109-7
Breast Cancer Research and Treatment
Scientia
Breast cancer research and treatment
Breast Cancer Research and Treatment
Scientia
Breast cancer research and treatment
Purpose Androgen receptor (AR) expression occurs in up to 86% of human epidermal growth factor receptor 2-positive (HER2+) breast cancers. In vitro, AR inhibitors enhance antitumor activity of trastuzumab, an anti-HER2 antibody, in trastuzumab-resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98cdcc0d199475dcadec98b642506659
https://lirias.kuleuven.be/handle/20.500.12942/705321
https://lirias.kuleuven.be/handle/20.500.12942/705321
Autor:
Monserrat Mangas, Flora López, Marc Diez, Juana María Cano, Alberto Carmona-Bayonas, Alfonso Martín Carnicero, Aitziber Gil-Negrete, Manuel Cánovas, Marcelo Garrido, Paula Cerdá, Paola Pimentel, Alicia Hurtado, Marta Martín Richard, Federico Longo, Carolina Hernández Pérez, Ana Montes, Rosario Vidal Tocino, Eva Martínez de Castro, Aranzazu Arias-Martinez, Javier Gallego, Mónica Granja, Laura Visa, Nieves Martinez Lago, Carles Pericay Pijaume, Natalia Castro Unanua, Avinash Ramchandani, Raquel Hernández, Ana Custodio, Tamara Sauri, Paula Jiménez-Fonseca, Gema Aguado, María Luisa Limón, Mariona Calvo, Aitor Azkarate
Publikováno v:
Scientia
Gastric Cancer
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FISABIO. Repositorio Institucional de Producción Científica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Gastric Cancer
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FISABIO. Repositorio Institucional de Producción Científica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Background The purpose of our study was to develop an online calculator to estimate the effect of docetaxel triplets (DPF) in first line of advanced gastric cancer (AGC), and to assess the external validity of docetaxel trials in individual patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82837869875d5aad20b11f5093a89906
https://hdl.handle.net/11351/7737
https://hdl.handle.net/11351/7737
Autor:
Martin J. van den Bent, Katerina Bakunina, Jacoline E C Bromberg, Linda Dirven, Samar Issa, Jeanette K. Doorduijn, Matthijs van der Meulen
Publikováno v:
Journal of Neuro-Oncology, 152(2), 357-362. Kluwer Academic
Journal of Neuro-Oncology, 152(2), 357-362. SPRINGER
Journal of Neuro-Oncology
Journal of Neuro-Oncology, 152(2), 357-362. SPRINGER
Journal of Neuro-Oncology
Introduction To assess the value of the Mini-Mental State Examination (MMSE)-score at baseline in predicting survival in adult primary central nervous system lymphoma (PCNSL) patients. Methods In the HOVON 105/ ALLG NHL 24 phase III study patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a7bd8dbbae5896422024956ad26b38f
https://hdl.handle.net/1887/3251117
https://hdl.handle.net/1887/3251117
Autor:
Lukas Schollenberger, Christoph Thomssen, Slavomir Krajnak, Nadia Harbeck, Thomas Decker, Christian Ruckes, Tanja Fehm, Marcus Schmidt, Christian Rose
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose Metronomic chemotherapy (MCT) is an increasingly used treatment option in hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) advanced/metastatic breast cancer (MBC) after failure of endocrine-based the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d71e18d1f5a367f18fa6e6cf0e457306
Autor:
Ana Custodio, Carolina Hernández Pérez, Mónica Granja, Aitor Azkarate, Aitziber Gil-Negrete, Laura Visa, Manuel Cánovas, Carles Pericay Pijaume, Tamara Sauri, Patricia Morales del Burgo, Gema Aguado, Felipe Alvarez-Manceñido, Olbia Serra, Paula Jiménez-Fonseca, Nieves Martinez Lago, M. Luisa Limon, Maria Alsina, Alicia Hurtado, Aranzazu Arias-Martinez, Alfonso Martín Carnicero, Javier Gallego, Ana Montes, P. Reguera, Paola Pimentel, Juana María Cano, Rosario Vidal Tocino, Virginia Arrazubi, Alberto Carmona-Bayonas, Diego Cacho Lavin, Alba Martinez-Torron, Avinash Ramchandani, Marta Martín Richard, Raquel Hernández, Flora López
Publikováno v:
Gastric Cancer
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FISABIO. Repositorio Institucional de Producción Científica
Background Advanced esophageal adenocarcinoma (EAC) is generally treated similarly to advanced gastroesophageal junction (GEJ-AC) and gastric (GAC) adenocarcinomas, although GAC clinical trials rarely include EAC. This work sought to compare clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb6610ee161c1b474b11a4778f667108
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4917
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4917
Autor:
Gessica Abate, Nadia Bulzonetti, Erika Moscarelli, Francesca De Felice, Daniela Musio, Vincenzo Tombolini
To evaluate treatment outcomes after definitive chemoradiotherapy (CRT) for human papilloma virus (HPV)-negative oropharyngeal squamous cell carcinoma (OPSCC). We analyzed data concerning HPV-negative OPSCC patients treated with curative intent. All
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bfc73d5dc8420ba6b2ec27f48151047
http://hdl.handle.net/11573/1360016
http://hdl.handle.net/11573/1360016
Autor:
Andrés Cervantes, Hans Wildiers, Michael C. Wei, Mafalda Oliveira, Carlos Becerra, Cristina Saura, John Bond, Heather M. Moore, Stephen Lane Richey, Todd M. Bauer, Ian E. Krop, Timothy R. Wilson, Philippe L. Bedard, Manish R. Patel, Vandana G Abramson, Na Cui, Eric Reyner
PURPOSE: This open-label, phase Ib, dose-escalation, and dose-expansion study (NCT01862081) evaluated taselisib with a taxane in locally advanced or metastatic breast cancer (BC) and/or non-small cell lung cancer (NSCLC). METHODS: Patients received t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f39f99cf25167457215cd64d3bc8206
https://lirias.kuleuven.be/handle/123456789/640324
https://lirias.kuleuven.be/handle/123456789/640324
Autor:
Kazuhiro Yamamoto, Masato Fujisawa, Midori Hirai, Hideaki Miyake, Tsutomu Nakagawa, Takuto Hara, Ikuko Yano
Publikováno v:
Targeted Oncology. 13(3):371-378
Background: The expression level of signal transducer and activator of transcription 3 (STAT3) in tumor cells is reported to associate with response to therapy and with survival time in various types of cancer. Objective: This retrospective study aim
Autor:
Megumi Furuta, Kei Takamura, Yuka Fujita, Masahiro Watanabe, Hirotoshi Dosaka-Akita, Hiroshi Nishihara, Takahiro Ogi, Eisaku Miyauchi, Toshiyuki Harada, Hajime Asahina, Noriyuki Yamada, Yasuyuki Ikezawa, Jun Sakakibara-Konishi, Masaharu Nishimura, Toraji Amano, Yasutaka Kawai, Satoshi Oizumi, Ichiro Kinoshita, Hiroshi Isobe
Publikováno v:
Cancer chemotherapy and pharmacology. 80(5):955-963
Purpose: A high proportion of patients with wild-type EGFR non-small cell lung cancer (NSCLC) receive third-line therapy and beyond, with no prospective randomized trials addressing the issue. This study aimed to select the most suitable regimen as a